Research & Development

Pharma CEOs Grapple With Huge R&D Costs

It’s not easy being a pharma CEO. The industry is currently taking a PR beating for raising the prices of its drugs, and not just for new medicines, but also ones that have been in the market for decades. But pharma CEOs counter that it’s increasingly tough to cover R&D expenses, though they are finding other ways to mitigate costs, including slashing other types of expenses and buying competitors.

CSL Behring’s Paul Perreault Talks about Driving Disciplined R&D

The pursuit of new drugs is just one way to navigate the “innovate or exit” pharma world.

R&D: In-house vs. Outsourcing—Making the Right Product Development Decision

Manufacturers are constantly looking at new technologies to improve processes, cut costs and expand the breadth and depth of products they provide to customers. But how do you decide on the best way to get access to the needed technology?

Examining the ROI of R&D

Today's tough economy demands more intense scrutiny of investments in innovation. Innovation is no longer sufficient in itself, but rather there is a new desire for metrics with which to measure success. But can you really measure ROI based on corporate investment?

Getting R&D Back on Track

BASIC RESEARCH, NOW AT RISK, NEEDS MAJOR ATTENTION.

Flight of the Creative Class

The U.S. must invest more in R&D and universities to retain its best and brightest.

Harnessing Innovation

Corporate VC arms fund smaller companies with big ideas.
- Advertisement -

FEATURED EVENTS

3rd Annual CEO Talent Summit
October 25-26, 2017
Orlando, Florida

Leadership Summit featuring Jim Collins
November 2-3, 2017
Denver, Colorado
- Advertisement -

SUBSCRIBE TO CHIEF EXECUTIVE

Sign Up to Receive Chief Executive’s Magazine and e-Newsletters

Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.

THOUGHT LEADERS

How to Respond When Bosses Misbehave

With all the bad CEO behavior out there lately, is it time to press reset?

Stops and Starts Along the Road to Globalization

Globalization hasn't stopped, it's simply on pause. What we’re seeing is not a reversal but a correction—a necessary rebalancing and search for equilibrium.

How the Org Chart has Given Way to the Network and Why it Matters

As they try to keep up with disruptive forces, companies shift their focus from human capital to social capital.

How Mark Vergnano Turned Around DuPont’s Failing Spin-Off

Stepping into a negative situation is never easy, but Mark Vergnano's step-by-step plan to turn around the company is proving successful.

CEO CONFIDENCE INDEX

Last 12 Months: CEO Confidence is on a Steady Uptick

Although it has dipped slightly in the last two months, CEO confidence made significant strides in the...

MOST POPULAR STORIES